What does a treatment plan and management strategy look like for high-risk multiple myeloma?
High-risk myeloma typically calls for a more aggressive and carefully coordinated approach. The goal is to attack the myeloma from multiple angles, achieve the deepest remission possible, and keep it there as long as possible.
Here's Show Full Answer
What does a treatment plan and management strategy look like for high-risk multiple myeloma?
High-risk myeloma typically calls for a more aggressive and carefully coordinated approach. The goal is to attack the myeloma from multiple angles, achieve the deepest remission possible, and keep it there as long as possible.
Here's a general overview of how treatment is typically structured:
Induction Therapy (First-Line Treatment)
- Usually starts with a combination of 3–4 drugs
- Common combinations include a proteasome inhibitor (like bortezomib/Velcade), an immunomodulatory drug (like lenalidomide/Revlimid), and a steroid (like dexamethasone)
- A monoclonal antibody like daratumumab is often added for high-risk cases, making it a 4-drug regimen Stem Cell Transplant
- For eligible patients, an autologous stem cell transplant (using your own stem cells) is often recommended after induction therapy
- High-dose chemotherapy (usually melphalan) is used to wipe out remaining myeloma before the transplant Consolidation Therapy
- After a transplant, a few more rounds of chemotherapy may be given to eliminate any remaining myeloma cells Maintenance Therapy
- Long-term, lower-dose treatment (often lenalidomide) is used to keep myeloma in remission as long as possible
- For high-risk patients, a proteasome inhibitor may be added to maintenance therapy Managing Bone Health
- About 85% of people with myeloma develop bone density loss or lesions
- Bisphosphonates or denosumab are commonly prescribed to strengthen bones and manage bone pain If Myeloma Returns (Relapse)
- New treatment lines are explored, including CAR T-cell therapy, newer drug combinations, or clinical trials
- Clinical trials are especially worth discussing for high-risk cases, as they may offer access to cutting-edge therapies not yet widely available Supportive Care Throughout
Supportive treatments play a big role in quality of life and include:
- Pain management
- Vaccinations (flu, pneumonia) to protect against infection
- Blood transfusions if needed
- Intravenous immunoglobulin (IVIG) to support the immune system
- Healthy lifestyle habits like nutrition and gentle exercise
Every treatment plan is highly personalized based on age, overall health, genetic markers of the myeloma, and how it responds to treatment. Working closely with a hematologist-oncologist who specializes in myeloma is really important, especially for high-risk cases.
3 days ago
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
